The hypervariable immunodominant NP_418-426 epitope from the influenza a virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidityBOON, Adrianus C. M; DE MUTSERT, Gerrie; FOUCHIER, Ron A. M et al.Journal of virology. 2006, Vol 80, Num 12, pp 6024-6032, issn 0022-538X, 9 p.Article

Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1KREIJTZ, Joost H. C. M; SUEZER, Yasemin; SUTTER, Gerd et al.The Journal of infectious diseases. 2007, Vol 195, Num 11, pp 1598-1606, issn 0022-1899, 9 p.Article

Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trialKREIJTZ, Joost H. C. M; GOEIJENBIER, Marco; FOUCHIER, Ron A. M et al.Lancet. Infectious diseases (print). 2014, Vol 14, Num 12, pp 1196-1207, issn 1473-3099, 12 p.Article

Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H 1 N 1 vaccine in the ferret modelKREIJTZ, Joost H. C. M; SÜZER, Yasemin; FOUCHIER, Ron A. M et al.Journal of general virology. 2010, Vol 91, pp 2745-2752, issn 0022-1317, 8 p., 11Article

Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxidtyVAN BAALEN, Carel A; KWA, David; VERSCHUREN, Esther J et al.The Journal of infectious diseases. 2005, Vol 192, Num 7, pp 1183-1190, issn 0022-1899, 8 p.Article